Liability insurance of drug clinical trial
Of the 29 new drug trials, 44.8% (13/29) of the sponsors purchased
commercial insurance for subjects during the trial. Interestingly, these
are trials evaluating BE and human pharmacokinetics. Such insurance is
usually for compensate for injury or death related to the
investigational drugs. In general, the cumulative liability limit is
generally between RMB 300,000 and RMB 500,000 per person. Since ChiCTR
platform does not require filling in relevant insurance information , it
is unclear whether the insurance is purchased or not on the
post-marketing studies.